CapsoVisionCV 10 FCF Margin % is -218.98% as of Mar. 2026. GuruFocus rates CV with a GF Score™ of 10/100. The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, CapsoVision ranks worse than 87.48% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. CapsoVision's Free Cash Flow for the
three
months ended in Mar. 2026 was $-6.11 Mil. CapsoVision's Revenue for the
three
months ended in Mar. 2026 was $2.79 Mil. Therefore, CapsoVision's FCF Margin % for the quarter that ended in Mar. 2026 was -218.98%.
The historical rank and industry rank for CapsoVision's FCF Margin % or its related term are showing as below:
CV'
s FCF Margin % Range Over the Past 10 Years
Min: -177.26 Med: -169.35 Max: -118.49
Current: -177.26
During the past 3 years, the highest FCF Margin % of CapsoVision was -118.49%. The lowest was -177.26%. And the median was -169.35%.
CV's FCF Margin % is ranked worse than 87.48% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs CV: -177.26
CapsoVision FCF Margin % Related Terms
CapsoVision FCF Margin % Historical Data
* Premium members only.
The historical data trend for CapsoVision's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, CapsoVision's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CapsoVision FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CapsoVision's FCF Margin % distribution charts can be found below:
* The bar in red indicates where CapsoVision's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CapsoVision (CV) has a FCF Margin % of -218.98% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on CapsoVision and its competitors. According to the industry distribution chart, CapsoVision ranks #713 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 87.5%.
Is CapsoVision's FCF Margin % too high?
CapsoVision's current FCF Margin % is -218.98%. Based on the distribution chart, CapsoVision ranks #713 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, CapsoVision has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does CapsoVision's FCF Margin % compare to SENS and MASS?
According to the Medical Devices & Instruments industry distribution chart, CapsoVision ranks #713 out of 815 companies for FCF Margin %. This places CapsoVision in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on CapsoVision and its competitors. CapsoVision's current FCF Margin % is -218.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CapsoVision stock overvalued right now?
CapsoVision (CV) has a current FCF Margin % of -218.98%. The current FCF Margin % is -218.98%. CapsoVision's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For CapsoVision (CV), the current FCF Margin % is -218.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
10GF Score
Get the complete analysis for CV
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CV has been successfully added to your 
